Mina Tadrous recognized by Canada's Drug Agency

Mina Tadrous, an assistant professor in the Leslie Dan Faculty of Pharmacy, has received the Dr. Maurice McGregor Award for a Rising Star in Health Technology Assessment from Canada’s Drug Agency.

This award honours an early-career professional who is pushing the science of health technology assessment (HTA) forward and helping to grow Canada’s reputation for excellence in the field.

Tadrous conducts research that has led to meaningful change at both the policy and patient level. At the Ontario Drug Policy Research Network, he played a key role in implementing a novel framework for drug class reviews that enhanced standard HTA methods with patient perspectives and real-world evidence.

Tadrous, who was appointed a tier 2 Canada Research Chair in Real World Evidence and Pharmaceutical Policy earlier this year, has also led work related to drug shortages, devising strategies that will help to safeguard Canada’s drug inventory.

Read about the Canada’s Drug Agency awards